New staged treatment shows promise for preventing psychosis in At-Risk youth

NCT ID NCT02751632

Completed Disease control Sponsor: Orygen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a step-by-step treatment approach for 342 young people aged 12-25 who are at ultra high risk of developing psychosis. The goal was to see if a sequence of therapies and medications could improve daily functioning and reduce the chance of psychosis. The approach uses a staged plan, starting with one treatment and adding others if needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICAL HIGH RISK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

personality disorder Personality Disorders Psychotic Disorders psychotic disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLINICAL HIGH RISK PERSONALITY DISORDERS PSYCHOTIC DISORDERS

Contacts and locations

Locations

Headspace

Craigieburn, Victoria, 3064, Australia
Headspace

Glenroy, Victoria, 3046, Australia
Headspace

Sunshine, Victoria, 3020, Australia
Headspace

Werribee, Victoria, 3030, Australia
Orygen Youth Health Clinical Program

Melbourne, Victoria, 3052, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.